Page last updated: 2024-10-21

8-phenyltheophylline and Obesity

8-phenyltheophylline has been researched along with Obesity in 2 studies

8-phenyltheophylline: purinergic P1 receptor antagonist

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Challis, RA1
Budohoski, L1
McManus, B1
Newsholme, EA1
Vannucci, SJ1
Klim, CM1
Martin, LF1
LaNoue, KF1

Other Studies

2 other studies available for 8-phenyltheophylline and Obesity

ArticleYear
Effects of an adenosine-receptor antagonist on insulin-resistance in soleus muscle from obese Zucker rats.
    The Biochemical journal, 1984, Aug-01, Volume: 221, Issue:3

    Topics: Animals; Glycogen; Glycolysis; In Vitro Techniques; Insulin; Lactates; Lactic Acid; Male; Muscles; O

1984
A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats.
    The American journal of physiology, 1989, Volume: 257, Issue:6 Pt 1

    Topics: Adenosine; Adenosine Deaminase; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adipose Tissue

1989